Ohad Kott
Papers
2
Total Citations
25
H-Index
2
About
Dr. Ohad Kott is a urologic surgeon and researcher whose work bridges the technical frontiers of surgical oncology and the molecular targeting of genitourinary cancers. His primary research areas include robotic-assisted surgery for renal masses and the development of novel, pH-targeted therapies for bladder cancer. Dr. Kott’s most cited work, “The BMI Paradox and Robotic Assisted Partial Nephrectomy” (2020, 17 citations), provides a critical analysis of how obesity affects perioperative outcomes in nephron-sparing surgery, challenging conventional assumptions and refining patient selection for this gold-standard procedure. In a more recent and innovative contribution, “Targeting bladder urothelial carcinoma with pHLIP-ICG and inhibition of urothelial cancer cell proliferation by pHLIP-amanitin” (2022, 8 citations), he demonstrates the use of pH Low Insertion Peptides (pHLIPs) to exploit tumor acidity as a biomarker. This work successfully delivers targeted imaging and therapeutic agents directly into cancer cells, offering a promising new avenue for precise, image-guided treatment and drug delivery in urothelial carcinoma. Through this dual focus on optimizing surgical technique and pioneering molecular targeting, Dr. Kott is making significant strides toward more personalized and effective care for patients with urologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1The BMI Paradox and Robotic Assisted Partial Nephrectomy17 citations · 2020
- 2